I've been holding back on some info for a bit now. Myer will be smashed in early 2019... why? Because of IFRS 16 - the new leases standard.
The new requirements eliminate nearly all off balance sheet accounting for lessees and redefine many commonly used financial metrics such as the gearing ratio, leverage and EBITDA. This will increase comparability, but may also affect covenants, credit ratings, borrowing costs and risk.
Once Myers $2.7b worth of leases are included on the balance sheet as liabilities, their leverage covenant of 2.5x will be breached (current 0.6x in FY17 to 12x in FY19). They may be able to request whats called "a freeze" but that just delays the inevitable. I don't see shorter's disappearing anytime soon. Also, this makes Myer less attractive as a takeover target as operating leases are now included as debt and increases the perceived risk of the business, hence less banks will lend to them making growth acquisitions difficult.
TLDR: Myers balance sheet looks ok since all its leases are off balance sheet. On January 2019, the $2.7b in leases that are off balance sheet have to be included on the balance sheet as liabilities.
- Forums
- ASX - By Stock
- MYR
- David Jones Takeover Talk
David Jones Takeover Talk, page-46
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
96.5¢ |
Change
0.045(4.89%) |
Mkt cap ! $808.2M |
Open | High | Low | Value | Volume |
92.0¢ | 97.0¢ | 92.0¢ | $1.915M | 2.031M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 914 | 96.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.0¢ | 18847 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 16544 | 0.920 |
3 | 13401 | 0.915 |
1 | 550 | 0.910 |
2 | 15555 | 0.900 |
4 | 24609 | 0.890 |
Price($) | Vol. | No. |
---|---|---|
0.970 | 3594 | 1 |
0.975 | 19556 | 2 |
0.980 | 44190 | 4 |
0.985 | 2290 | 2 |
0.990 | 38701 | 5 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
MYR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online